The indoleamine 2,3‐dioxygenase (IDO) pathway controls allergy
Authors:
Open Access
Abstract
A series of recent studies have demonstrated that the immunoregulatory pathway of tryptophan catabolism, initiated by the enzyme indoleamine 2,3‐dioxygenase (IDO), is a critical participant in allergic inflammation. Originally known for its regulatory function during pregnancy and during chronic inflammation in tumorigenesis and infection, the activity of IDO seems to positively modify the inflammatory state of atopy or allergy. The tryptophan degradation pathway is important for tolerance induction during systemic allergen immunotherapy. Here, we focus on recent findings that establish the IDO pathway as central to allergic inflammation.Keywords
This publication has 63 references indexed in Scilit:
- Identification of a Variable Number of Tandem Repeats Polymorphism and Characterization of LEF-1 Response Elements in the Promoter of the IDO1 GenePLOS ONE, 2011
- Vascular Endothelial Expression of Indoleamine 2,3-Dioxygenase 1 Forms a Positive Gradient towards the Feto-Maternal InterfacePLOS ONE, 2011
- Towards a Genetic Definition of Cancer-Associated InflammationThe American Journal of Pathology, 2010
- IDO Activates Regulatory T Cells and Blocks Their Conversion into Th17-Like T CellsThe Journal of Immunology, 2009
- Relationships among body mass, brain size, gut length, and blood tryptophan and serotonin in young wild-type miceBMC Physiology, 2009
- Exploring the mechanism of tryptophan 2,3-dioxygenaseBiochemical Society Transactions, 2008
- Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammationProceedings of the National Academy of Sciences, 2008
- Indoleamine 2,3-Dioxygenase (IDO)The American Journal of Pathology, 2007
- Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenaseJournal of Clinical Investigation, 2007
- Human Epidermal Langerhans Cells Express the Immunoregulatory Enzyme Indoleamine 2,3-DioxygenaseJournal of Investigative Dermatology, 2004